Composition
Lansoprazole pellets 352.943 mg (equivalent to Lansoprazole 30 mg).

 Indications
- Treatment of duodenal and gastric ulcer.
- Treatment & Prophylaxis of reflux oesophagitis.
- Eradication of Helicobacter Pylori (H.Pylori) concurrently given with appropriate antibiotic therapy.
- Treatment & Prophylaxis of NSAID-associated benign gastric and duodenal ulcers.
- Zollinger-Ellison syndrome.

 Dosage
- Treatment of duodenal ulcer: One Capsule daily for 2 to 4 weeks.
- Treatment of gastric ulcer: One Capsule daily for 4 to 8 weeks.
- Reflux oesophagitis: One Capsule daily for 4 to 8 weeks
- Prophylaxis of reflux oesophagitis: One Capsule daily.
- Eradication of Helicobacter pylori: One Capsule twice daily for 7 days in combination with appropriate antibacterial agent.
- Treatment of NSAID associated benign gastric and duodenal ulcers: One Capsule daily for 4 to 8 weeks.
- Zollinger-Ellison syndrome: Two Capsules daily. The dose should be individually adjusted. Daily doses of up to 6 capsules have been used.

 How Supplied
Carton Box containing (AL/opaque PVC) strip of 10 hard gelatin capsules containing Lansoprazole pellets.

Clinical Pharmacology
Pharmacotherapeutic group: Proton pump inhibitors.
Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach.
The inhibition is dose dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid.